Shaanxi Panlong Pharmaceutical Group Co., Ltd. (SHE:002864)
China flag China · Delayed Price · Currency is CNY
27.05
-0.38 (-1.39%)
Jun 11, 2026, 3:04 PM CST

SHE:002864 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
1,1111,139971.45978.2971.04883.76
Other Revenue
1.881.882.412.633.263.73
1,1131,141973.86980.83974.29887.48
Revenue Growth (YoY)
9.79%17.15%-0.71%0.67%9.78%32.40%
Cost of Revenue
534.39549.24381.74413.74408.25370.36
Gross Profit
578.81591.62592.12567.09566.04517.12
Selling, General & Admin
403.58416.56436.86418.79416.11386.15
Research & Development
51.8953.1137.5420.2618.2314.03
Other Operating Expenses
12.9111.169.3510.6110.239.29
Operating Expenses
491.79504.81485.59453.98452.94414.07
Operating Income
87.0186.81106.53113.11113.1103.05
Interest Expense
-1.97-2.18-1.56-6.11-13.92-3.49
Interest & Investment Income
9.4214.5525.5822.0617.1811.78
Other Non Operating Income (Expenses)
-2.38-0.58-0.220.312.55-5.27
EBT Excluding Unusual Items
92.0898.6130.32129.37118.91106.06
Gain (Loss) on Sale of Investments
-0.13-0.13--1.56-0.11-
Gain (Loss) on Sale of Assets
0.130.13-0.010.17--
Asset Writedown
-0.2-0.01-0.18-0.81-0.08-0
Other Unusual Items
14.4510.376.822.080.462.97
Pretax Income
106.32108.95136.95129.25119.18109.03
Income Tax Expense
19.7312.9317.0317.716.0314.47
Earnings From Continuing Operations
86.5996.02119.92111.55103.1594.56
Minority Interest in Earnings
0.20.260.35-1.11-1.98-1.39
Net Income
86.7996.28120.27110.43101.1693.17
Net Income to Common
86.7996.28120.27110.43101.1693.17
Net Income Growth
-27.90%-19.95%8.91%9.16%8.58%17.77%
Shares Outstanding (Basic)
105105105968685
Shares Outstanding (Diluted)
105105105988685
Shares Change (YoY)
-0.15%0.07%7.02%13.03%1.16%-0.60%
EPS (Basic)
0.830.921.151.151.181.09
EPS (Diluted)
0.830.921.151.131.171.09
EPS Growth
-27.79%-20.00%1.77%-3.42%7.34%18.48%
Free Cash Flow
101.5920.674.5441.5369.5335.36
Free Cash Flow Per Share
0.970.200.710.420.800.41
Dividend Per Share
0.3500.3500.2500.2200.2000.180
Dividend Growth
40.00%40.00%13.64%10.00%11.11%20.00%
Gross Margin
52.00%51.86%60.80%57.82%58.10%58.27%
Operating Margin
7.82%7.61%10.94%11.53%11.61%11.61%
Profit Margin
7.80%8.44%12.35%11.26%10.38%10.50%
Free Cash Flow Margin
9.13%1.81%7.65%4.23%7.14%3.98%
EBITDA
124.31123.15139.04142.92130.16117.8
EBITDA Margin
11.17%10.79%14.28%14.57%13.36%13.27%
D&A For EBITDA
37.336.3432.5129.8117.0714.74
EBIT
87.0186.81106.53113.11113.1103.05
EBIT Margin
7.82%7.61%10.94%11.53%11.61%11.61%
Effective Tax Rate
18.56%11.87%12.43%13.70%13.45%13.27%
Revenue as Reported
1,1131,141973.86980.83974.29887.48
Advertising Expenses
-1.35.041.091.763.68